GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sci Pharmtech Inc (TPE:4119) » Definitions » EPS (Diluted)

Sci Pharmtech (TPE:4119) EPS (Diluted) : NT$3.99 (TTM As of Sep. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Sci Pharmtech EPS (Diluted)?

Sci Pharmtech's Earnings per Share (Diluted) for the three months ended in Sep. 2024 was NT$3.18. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was NT$3.99.

Sci Pharmtech's EPS (Basic) for the three months ended in Sep. 2024 was NT$3.19. Its EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2024 was NT$4.00.

Sci Pharmtech's EPS without NRI for the three months ended in Sep. 2024 was NT$3.18. Its EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2024 was NT$3.98.

During the past 12 months, Sci Pharmtech's average EPS without NRIGrowth Rate was 11.20% per year. During the past 3 years, the average EPS without NRIGrowth Rate was -7.20% per year. During the past 5 years, the average EPS without NRI Growth Rate was -14.80% per year. During the past 10 years, the average EPS without NRI Growth Rate was -1.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Sci Pharmtech's highest 3-Year average EPS without NRI Growth Rate was 36.00% per year. The lowest was -50.60% per year. And the median was 5.40% per year.


Sci Pharmtech EPS (Diluted) Historical Data

The historical data trend for Sci Pharmtech's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sci Pharmtech EPS (Diluted) Chart

Sci Pharmtech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EPS (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.19 3.28 0.51 2.87 2.69

Sci Pharmtech Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.33 -0.08 0.37 0.52 3.18

Competitive Comparison of Sci Pharmtech's EPS (Diluted)

For the Drug Manufacturers - Specialty & Generic subindustry, Sci Pharmtech's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sci Pharmtech's PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sci Pharmtech's PE Ratio distribution charts can be found below:

* The bar in red indicates where Sci Pharmtech's PE Ratio falls into.



Sci Pharmtech EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Sci Pharmtech's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as

Diluted EPS (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(294.721-0)/109.609
=2.69

Sci Pharmtech's Diluted EPS for the quarter that ended in Sep. 2024 is calculated as

Diluted EPS (Q: Sep. 2024 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(381.146-0)/119.857
=3.18

EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$3.99

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sci Pharmtech  (TPE:4119) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Sci Pharmtech EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Sci Pharmtech's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Sci Pharmtech Business Description

Traded in Other Exchanges
N/A
Address
No.61, Lane 309, Haihu North Road, Luzhu District, Taoyuan, TWN, 33856
Sci Pharmtech Inc is engaged in the research and development, manufacture, and sale of active pharmaceutical ingredients, intermediates, and specialty chemicals. Geographically, the primary markets of the company are Italy, Germany, Japan, Taiwan, the United States, China, Switzerland, Spain, and others.

Sci Pharmtech Headlines

No Headlines